Table 2.
Penetrance |
||||
Modela andLiabilityClass | dd | Dd | DD | Description |
A: | ||||
1 | .001 | 1 | 1 | All affected men |
2 | .5 | .5 | .5 | Unaffected men aged <75 years and all women |
3 | .84 | .37 | .37 | Unaffected men aged ⩾75 years |
B: | ||||
1 | .00038 | .0018 | .0018 | Affected men aged ⩽49 years at diagnosis |
2 | .00061 | .0084 | .0084 | Affected men aged 50–59 years at diagnosis |
3 | .0032 | .03 | .03 | Affected men aged 60–69 years at diagnosis |
4 | .0082 | .04 | .04 | Affected men aged 70–79 years at diagnosis |
5 | .0086 | .015 | .015 | Affected men aged ⩾80 years at diagnosis |
6 | .99981 | .9908 | .9908 | Unaffected men aged ⩽49 years |
7 | .9968 | .94 | .94 | Unaffected men aged 50–59 years |
8 | .978 | .75 | .75 | Unaffected men aged 60–69 years |
9 | .921 | .39 | .39 | Unaffected men aged 70–74 years |
10 | .84 | .12 | .12 | Unaffected men aged ⩾75 years |
11 | .5 | .5 | .5 | Unknown and all women |
For both model A and model B, disease-gene frequency fD = .003.